Structure-based inhibitors reveal roles for the clathrin terminal domain and its W-box binding site in CME
Z. Chen, R. Mino, M. Mettlen, P. Michaely, M. Bhave, D. K. Reed, S. L. Schmid
The paper identifies the role of clathrin's N-terminal domain in CME and develops a peptide inhibitor that specifically blocks CME without affecting other endocytic processes.
Journal of Cell Biology · Jun 10, 2020Peer-reviewedCell Biology